TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13 April 10, 1981
TCL Archive Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit. October 26, 2001